Clinical Trials in France — Country Dashboard | 4,497 EU Studies

Filter these 4,497 trials by condition, phase, sponsor and more.

Open in Search →

4,497 Registered trials

1,845 Recruiting

2,148 Completed trials

905 Sponsors active

1,193 Research sites

Phase III

Phase II

Phase III: 1870 Phase II/III: 208 Phase II: 1262 Phase I/II: 286 Phase III/IV: 51 Phase IV: 173 Phase I: 239 Phase I (Other): 177 Phase I (FiH): 218 Other: 8 Other: 5

Oversight events in trials active here:

104 serious breaches 882 temporary halts 92 urgent safety measures 105 unexpected events 179 corrective measures across 542 trials

View oversight register →

Top conditions

Non-small cell lung cancer 154 Non-small cell lung cancer metastatic 52 Colorectal cancer 39 Ovarian cancer 37 Squamous cell carcinoma of head and neck 32 Systemic lupus erythematosus 30 Endometrial cancer 28 Breast cancer 28 Non-small cell lung cancer stage IV 27 Myelodysplastic syndrome 27 Diffuse large B-cell lymphoma 26 Triple negative breast cancer 26

Top sponsors

Assistance Publique Hopitaux De Paris 264 Centre Hospitalier Universitaire De Nantes 195 Merck Sharp & Dohme LLC 177 Novartis Pharma AG 165 F. Hoffmann-La Roche AG 144 AstraZeneca AB 143 Janssen - Cilag International 115 AbbVie Deutschland GmbH & Co. KG 97 Sanofi-Aventis Recherche & Developpement 72 Glaxosmithkline Research & Development Limited 66 Bristol-Myers Squibb Services Unlimited Company 65 Unicancer 65

Cities with most trials

All 448 cities →

All trials — page 41

4,497 total

Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting

2025-523207-29-00 Phase IV colorectal cancer laparoscopic surgery Centre Hospitalier Universitaire Amiens Picardie
Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Plac… Recruiting

2023-507801-32-00 Phase IV Isolated Subsegmental Pulmonary Embolism Insel Gruppe AG
A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting

2024-520014-22-00 Phase III Locally advanced/metastatic urothelial carcinoma Merck Sharp & Dohme LLC
SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting

2025-521560-36-00 Phase II Type 1 Diabetes Sab Biotherapeutics Inc.
A study to test the effects and safety of palopegteriparatide in adolescents with long-term hypoparathyroidism Recruiting

2025-523928-52-00 Phase III Chronic hypoparathyroidism Ascendis Pharma Bone Diseases A/S
Efficacy of early continuous infusion of hypertonic saline solution on the neurological outcome at 6 months in traumatic brain injured patie… Recruiting

2024-520205-39-00 Phase III Traumatic brain injury Centre Hospitalier Universitaire De Nantes
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Phase III Secondary progressive multiple sclerosis Novartis Pharma AG
Clindamycin as an alternative to vancomycin in patients undergoing aortic cardiac surgery with extracorporeal circulation (ECC): a prospecti… Recruiting

2025-521555-23-00 Phase II Patients undergoing cardiac surgery with extracorporeal circ… Centre Hospitalier Universitaire De Nantes
A clinical study to investigate the efficacy and safety of an investigational combination therapy with BNT324 and BNT327 in patients with ad… Recruiting

2024-520238-31-01 Phase I/II Advanced Lung Cancer BioNTech SE
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Advanced Liver Cancers (M… Recruiting

2023-506611-17-00 Phase I/II Advanced liver cancers F. Hoffmann-La Roche AG
Testing HLX43 in Advanced Lung Cancer (Non-Small Cell): A Global Safety and Effectiveness Study Recruiting

2025-523803-31-00 Phase II Advanced non-small cell lung cancer (NSCLC) Shanghai Henlius Biotech Inc.
A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Statur… Recruiting

2025-523079-44-00 Phase III Turner Syndrome (TS) Ascendis Pharma Endocrinology Division A/S
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma Recruiting

2025-524542-10-00 Phase II Endometrial cancer Acrivon Therapeutics Inc.
A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting

2025-521012-18-00 Phase III Facioscapulohumeral Muscular Dystrophy (FSHD) Avidity Biosciences Inc.
A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy… Recruiting

2025-523085-24-00 Phase III Biliary Tract Cancer AstraZeneca AB
Open-label extension study with filgotinib in children with juvenile idiopathic arthritis. Recruiting

2025-523239-21-00 Phase III Juvenile idiopathic arthritis Alfasigma S.p.A.
Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock … Recruiting

2024-518493-14-00 Phase II/III kidney transplant Les Hopitaux Universitaires De Strasbourg
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Phase III Uveal Melanoma Ideaya Biosciences Inc.
Evaluating oral peri-operative acetylsalicylic acid in subjects undergoing endovascular coiling-only of unruptured brain aneurysms Recruiting

2024-517674-23-00 Phase III Subjects undergoing elective endovascular coiling-only repai… University Of Calgary
C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer. Recruiting

2025-521756-39-00 Phase I Non-muscle invasive bladder cancer (NMIBC) Pfizer Inc.
Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Previously Untreated Advanced or Me… Recruiting

2025-523263-37-00 Phase II/III Previously Untreated Advanced or Metastatic Gastric, Gastroe… Bristol-Myers Squibb Services Unlimited Company
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting

2025-523686-15-00 Phase I Advanced or Metastatic Solid Tumors Olema Pharmaceuticals Inc.
BCS-ORL - Evaluation of the superficial cervical plexus block in oncological throat and neck surgery Recruiting

2024-510942-15-00 Phase III Cancer surgery Assistance Publique Hopitaux De Paris
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib plus Ribociclib plus Fulvestrant Versus Placebo plus Ribociclib plus Fulve… Recruiting

2025-523013-28-00 Phase II Endocrine-Resistant Hormone-Receptor-Positive, HER2-Negative… F. Hoffmann-La Roche AG

Showing 961–984 of 4,497 trials

← All countries